Geographic latitude and the efficacy of bacillus Calmette-Guérin vaccine
- PMID: 7795103
- DOI: 10.1093/clinids/20.4.982
Geographic latitude and the efficacy of bacillus Calmette-Guérin vaccine
Abstract
In a meta-analysis of the efficacy of BCG vaccine for preventing tuberculosis, study sites at a greater distance from the equator were associated with a higher efficacy. In a random-effects regression analysis of prospective studies, geographic latitude alone accounted for 41% of the between-study variance. Many factors that vary with latitude may influence the effectiveness of BCG vaccine by modifying the susceptibility of human hosts, the pathogenecity of the organism, or host-agent interactions. These factors include socioeconomic conditions, genetic composition of the population, climate, exposure to sunlight, diet and nutrition, presence of nontuberculous mycobacteria in the environment, completeness of surveillance and follow-up in studies of BCG vaccine, virulence of locally prevalent strains of Mycobacterium tuberculosis, and storage and viability of BCG vaccine. This paper describes the biological plausibility, epidemiologic evidence, and other scientific data bearing on the influence of these factors on the efficacy of BCG vaccine.
Similar articles
-
The geographic location (latitude) of studies evaluating protective effect of BCG vaccine and it's efficacy/effectiveness against tuberculosis.Indian J Public Health. 2007 Oct-Dec;51(4):205-10. Indian J Public Health. 2007. PMID: 18232158
-
The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.Pediatrics. 1995 Jul;96(1 Pt 1):29-35. Pediatrics. 1995. PMID: 7596718
-
The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.MMWR Recomm Rep. 1996 Apr 26;45(RR-4):1-18. MMWR Recomm Rep. 1996. PMID: 8602127
-
Diagnosis and Management of Infections in Patients with Mendelian Susceptibility to Mycobacterial Disease.Pathogens. 2024 Feb 25;13(3):203. doi: 10.3390/pathogens13030203. Pathogens. 2024. PMID: 38535546 Free PMC article. Review.
-
Bacterial vaccine vectors and bacillus Calmette-Guérin.Clin Infect Dis. 1995 Apr;20(4):1001-9. doi: 10.1093/clinids/20.4.1001. Clin Infect Dis. 1995. PMID: 7795044 Review.
Cited by
-
Vaccines against tuberculosis: where are we and where do we need to go?PLoS Pathog. 2012;8(5):e1002607. doi: 10.1371/journal.ppat.1002607. Epub 2012 May 10. PLoS Pathog. 2012. PMID: 22589713 Free PMC article. Review.
-
The use of Bacille Calmette-Guérin vaccination in children.Can J Infect Dis. 1995 Sep;6(5):232-3. doi: 10.1155/1995/587856. Can J Infect Dis. 1995. PMID: 22514402 Free PMC article. No abstract available.
-
Harnessing Mycobacterium bovis BCG Trained Immunity to Control Human and Bovine Babesiosis.Vaccines (Basel). 2022 Jan 14;10(1):123. doi: 10.3390/vaccines10010123. Vaccines (Basel). 2022. PMID: 35062784 Free PMC article. Review.
-
The potential impact of vaccination on tuberculosis burden in India: A modelling analysis.Indian J Med Res. 2023 Feb-Mar;157(2&3):119-126. doi: 10.4103/ijmr.ijmr_328_23. Indian J Med Res. 2023. PMID: 37202930 Free PMC article.
-
Factors associated with tuberculosis infection, and with anti-mycobacterial immune responses, among five year olds BCG-immunised at birth in Entebbe, Uganda.Vaccine. 2015 Feb 4;33(6):796-804. doi: 10.1016/j.vaccine.2014.12.015. Epub 2014 Dec 19. Vaccine. 2015. PMID: 25529292 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical